1.7001
price up icon0.01%   0.000100
after-market Handel nachbörslich: 1.70 -0.000100 -0.01%
loading
Schlusskurs vom Vortag:
$1.70
Offen:
$1.8
24-Stunden-Volumen:
12,805
Relative Volume:
0.49
Marktkapitalisierung:
$10.14M
Einnahmen:
$2.35M
Nettoeinkommen (Verlust:
$-2.56M
KGV:
-3.794
EPS:
-0.4481
Netto-Cashflow:
-
1W Leistung:
-4.00%
1M Leistung:
-12.82%
6M Leistung:
-15.00%
1J Leistung:
-26.08%
1-Tages-Spanne:
Value
$1.7001
$1.8099
1-Wochen-Bereich:
Value
$1.6901
$1.94
52-Wochen-Spanne:
Value
$1.50
$2.87

Immuron Limited Adr Stock (IMRN) Company Profile

Name
Firmenname
Immuron Limited Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
7
Name
Twitter
@ImmuronLtd
Name
Nächster Verdiensttermin
2024-08-27
Name
Neueste SEC-Einreichungen
Name
IMRN's Discussions on Twitter

Vergleichen Sie IMRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMRN
Immuron Limited Adr
1.7001 10.14M 2.35M -2.56M 0 -0.4481
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Immuron Limited Adr Aktie (IMRN) Neueste Nachrichten

pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX By Investing.com - Investing.com UK

Jun 04, 2025
pulisher
May 30, 2025

Immuron Letter to Shareholders: Projects Update - GlobeNewswire Inc.

May 30, 2025
pulisher
Mar 05, 2025

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - Markets Insider

Mar 05, 2025
pulisher
Jan 30, 2025

Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network

Jan 30, 2025
pulisher
Oct 04, 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - GlobeNewswire

Oct 04, 2024
pulisher
Sep 05, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review - GlobeNewswire

Sep 05, 2024
pulisher
Jul 02, 2024

Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewswire

Jul 02, 2024
pulisher
Apr 10, 2024

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider

Apr 10, 2024
pulisher
Mar 07, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com UK

Mar 07, 2024
pulisher
May 16, 2023

Immuron Limited Announces Participation in the LD Micro Invitational XIII - The Kingston Whig-Standard

May 16, 2023
pulisher
Jan 25, 2023

Immuron US DoD Naval Medical Research Center responds to - GlobeNewswire

Jan 25, 2023
pulisher
Dec 01, 2022

Immuron Surges On U.S. DoD Funding For Travelan Research By Investing.com - Investing.com Nigeria

Dec 01, 2022
pulisher
Jul 26, 2022

Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic - StockTitan

Jul 26, 2022
pulisher
Jan 19, 2022

Immuron LimitedADR Shares Close the Week 61.5% HigherWeekly Wrap - Nasdaq

Jan 19, 2022
pulisher
Sep 10, 2020

IMRNImmuron Ltd Latest Stock News & Market Updates - Stock Titan

Sep 10, 2020
pulisher
Feb 03, 2020

Immuron’s Technology Platform of Treatments in the Age of the Coronavirus Outbreak - GlobeNewswire

Feb 03, 2020
pulisher
Jun 27, 2018

Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView

Jun 27, 2018
pulisher
Mar 08, 2018

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.33% - Investing.com

Mar 08, 2018
pulisher
Mar 07, 2018

Immuron Limited Issues Correction to Misleading Halt Announcement Headline - GlobeNewswire

Mar 07, 2018
pulisher
Jul 19, 2017

IMC Stock Price and Chart — ASX:IMC - TradingView

Jul 19, 2017

Finanzdaten der Immuron Limited Adr-Aktie (IMRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):